Release Date: August 9, 2024 (United States)
Runtime: 1 hour 19 minutes
Country of Origin: United States
Language: English
Production Company: Peppermint Films
Budget: $2,000 (estimated)
Directors: Jacob Kau and Rohan Khehar
Writers: Colin Bae, Jacob Kau, and Rohan Khehar
Storyline
“Malady Rising” tells the emotional story of Harry, a powerful corporate lawyer who seemingly has it all—until a devastating car accident leaves him with severe physical injuries. Struggling with depression and feeling that his life has lost meaning, Harry spirals into despair. His journey towards healing takes a surprising turn when he meets Evangeline, an angelic nurse who not only tends to his physical wounds but also helps him mend his emotional scars. As she brings light back into his life, Harry finds a new purpose, realizing that true strength lies in vulnerability and the connections we build with others.
Characters
Harry (played by Royce Mealin Jr.): A successful corporate lawyer whose life is shattered by a car accident, leaving him to grapple with physical and emotional scars.
Evangeline (played by Dominique Izabella Little): A nurturing and empathetic nurse who plays a pivotal role in Harry’s journey to healing.
Reviews
Review by Critics: Malady Rising has received recognition for its moving examination of trauma and recovery. The performances, particularly by Royce Mealin Jr. and Dominique Izabella Little, have been lauded for their depth and authenticity. The film’s tight runtime ensures a focused narrative, though some critics noted that certain emotional beats felt rushed.
Review by the audience: The film’s close-knit narrative and the chemistry between the leads have won over viewers. It is been called a profoundly moving experience by many, and some have even called it one of 2024’s underappreciated gems.
Box-Office Collection
Given its modest budget of $2,000, “Malady Rising” performed admirably at the box office, grossing an estimated $120,000 in its opening weekend. The film has shown steady growth in ticket sales, largely driven by positive word of mouth and strong reviews. As of its third week in theaters, the film has grossed approximately $450,000 globally, a significant success considering its limited release and budget constraints.
